Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Caspofungin · Cancidas, Caspofungin Acetate

Small molecule · Inhibitor of 1,3-beta-glucan synthase · developed by Merck

Approved FDA, Jan 2001
1 Registered trials

What is Caspofungin?

Caspofungin is an echinocandin antifungal lipopeptide that inhibits 1,3-beta-glucan synthase, reducing synthesis of beta(1,3)-D-glucan, an essential component of the fungal cell wall. It is active against Aspergillus and Candida species. It is used in the treatment of candidiasis and invasive fungal infections, including candidemia.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Cancidas, Caspofungin Acetate, Echinocandin
Drug type
Small molecule
Targets
1,3-beta-glucan synthase
Mechanism
Inhibitor of 1,3-beta-glucan synthase
Pathways
fungal cell wall beta(1,3)-D-glucan synthesis
Therapy area
Infectious disease
Developer
Merck
In trials of
SCYX
FDA status
Approved as Cancidas, Caspofungin Acetate (January 26, 2001), NDA021227 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Jan 8, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05178862 Phase 3 Candidiasis, Invasive Terminated SCYX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

CandidemiaCandidiasis, Invasive

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.